Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Dermacell ADM Without Basement Membrane

for
Breast Cancer
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: Female

Age: 18 - 70+

Code: NCT03667560

Recruiting

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

for
Breast Cancer, Ovarian Cancer
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 25+

Code: NCT06760507

Recruiting

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

for
Mesothelioma, Epithelioid Hemangioendothelioma(EHE),
Location: Houston TX
Sponsor: BridGene Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06452160

Phase 1, Recruiting

Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy

for
Breast Cancer (Triple Negative Breast Cancer (TNBC)),
Location: Nashville TN
Sponsor: Jessica Mezzanotte Sharpe

Sex: All

Age: 18+

Code: NCT07555210

Recruiting

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

for
Vaginal Atrophy, Breast Carcinoma
Location: Ann Arbor MI, Des Moines IA
Sponsor: Alliance for Clinical Trials in Oncology

Sex: Female

Age: 22+

Code: NCT05379153

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

for
Metastatic Breast Cancer
Location: Boston MA, New Haven CT, Fairfax VA, Sarasota FL,
Sponsor: Janssen Research & Development, LLC

Sex: Female

Age: 18+

Code: NCT07524855

Phase 1, Recruiting

Supportive Care Intervention for Outpatient Stem Cell Transplant Patients

for
Hematopoietic Stem Cell Transplantation, Cancer
Location: Boston MA
Sponsor: Victor Wang

Sex: All

Age: 19+

Code: NCT06564233

Recruiting

Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

for
Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07276880

Phase 2, Recruiting

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, Hackensack NJ, St Louis MO, San Antonio TX
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07414836

Phase 1, Recruiting

A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer

for
Adult Cancer Patients, Right Atrial Clot
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07549477

Recruiting

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

for
Sentinel Lymph Node Biopsy, Breast Cancer
Location: Savannah GA
Sponsor: Memorial Health University Medical Center

Sex: Female

Age: 18+

Code: NCT03199560

Recruiting

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

for
Cancer, Advanced Cancer, Advanced Solid Tumor,
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT05166694

Recruiting

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

for
Solid Tumor, Adult
Location: Boston MA, New Haven CT, Orlando FL, Birmingham AL,
Sponsor: Corbus Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06265727

Phase 1, Phase 2, Recruiting

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

for
Childhood Malignant Solid Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 0 - 17

Code: NCT06915727

Phase 3, Recruiting

A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

for
Advanced Solid Tumors, Non-Small Cell Lung Cancer
Location: Ohio City OH
Sponsor: Chong Kun Dang Pharmaceutical

Sex: All

Age: 19+

Code: NCT07439094

Phase 1, Phase 2, Recruiting

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

for
Von Hippel-Lindau Disease, Malignant Neoplasms
Location: Boston MA, Philadelphia PA, Pittsburgh PA, Detroit MI,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07405164

Phase 3, Recruiting

A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial

for
Anatomic Stage 0 Breast Cancer AJCC v8,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 0+

Code: NCT07443943

Phase 2, Recruiting

Utility of a Mobile Application for Young Women With Breast Cancer

for
Breast Cancer, Cancer Distress
Location: Charlotte NC
Sponsor: Wake Forest University Health Sciences

Sex: Female

Age: 18 - 45

Code: NCT07009093

Recruiting

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC),
Location: Boston MA, Philadelphia PA, Fairfax VA, Tampa FL,
Sponsor: Kestrel Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07458347

Phase 1, Recruiting

Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

for
Dermatologic Diseases
Location: Irvine CA
Sponsor: University of California, Irvine

Sex: All

Age: 16+

Code: NCT00842283

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial